About
Team
Pipeline
OPN-2853
OPN-6602
OPN-FMRP
OPN-7486
OPN-9840
OPN-9627
Patients
News
Press Releases
Publications
& Posters
Careers
Contact
General information
info@opnabio.com
Investor inquiries
bd@opnabio.com
Media and BD inquiries
bd@opnabio.com
2022
Select PROGRAMS
All Programs
OPN-2853
(8)
OPN-51107
(17)
OPN-6602
(2)
OPN-7486
(5)
OPN-TEAD
(1)
Select Dates
All Dates
2024
(2)
2023
(3)
2022
(1)
2021
(3)
2020
(3)
2019
(7)
2018
(4)
2017
(3)
2016
(2)
2015
(3)
May 31, 2022
Publication
Major clinical response in a patient with leukemia cutis treated with the bromodomain inhibitor PLX51107 and azacitidine
AUTHORS
Kim, et al
Programs
OPN-51107
https://doi.org/10.1016/j.leukres.2022.106884